Literature DB >> 12523925

Celecoxib-related renal papillary necrosis.

Laila Akhund1, Robert J Quinet, Saliha Ishaq.   

Abstract

Selective cyclooxygenase 2 (COX-2) inhibitors are known to affect renal prostaglandins (epoprostenol and dinoprostone), which are at least in part COX-2 dependent. Consequently, adverse events including hypertension, peripheral edema, hypercalemia, hyponatremia, and acute renal failure have been reported to occur with the new COX-2-specific inhibitors. This case report posits celecoxib as a likely cause of renal papillary necrosis and alerts physicians to the possibility of this additional renal complication with COX-2-specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12523925     DOI: 10.1001/archinte.163.1.114

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Late-onset celecoxib-induced combined hepato-nephrotoxicity.

Authors:  James H Tabibian; Neshan Tabibian; David M Kaufman
Journal:  Br J Clin Pharmacol       Date:  2008-03-05       Impact factor: 4.335

2.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

3.  Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis.

Authors:  Nitya N Pathak; Madhu C Lingaraju; Venkanna Balaganur; Vinay Kant; Amar S More; Dhirendra Kumar; Dinesh Kumar; Surendra K Tandan
Journal:  Inflamm Res       Date:  2015-01-18       Impact factor: 4.575

4.  Implications of designing a bromelain loaded enteric nanoformulation on its stability and anti-inflammatory potential upon oral administration.

Authors:  Manu Sharma; Rishu Sharma
Journal:  RSC Adv       Date:  2018-01-11       Impact factor: 4.036

5.  Renal Medullary Interstitial COX-2 (Cyclooxygenase-2) Is Essential in Preventing Salt-Sensitive Hypertension and Maintaining Renal Inner Medulla/Papilla Structural Integrity.

Authors:  Ming-Zhi Zhang; Suwan Wang; Yinqiu Wang; Yahua Zhang; Chuan Ming Hao; Raymond C Harris
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

6.  Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study.

Authors:  Wisit Kaewput; Preedee Disorn; Bancha Satirapoj
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-11-07

Review 7.  Use of NSAIDs in treating patients with arthritis.

Authors:  Leslie J Crofford
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.